FINWIRES · TerminalLIVE
FINWIRES

調査速報:マテル社、第1四半期決算はまちまちだったものの、国際事業は好調

By

-- 独立系調査会社CFRAは、に対し、以下の調査レポートを提供しました。CFRAのアナリストは、以下のように見解をまとめています。MATは2026年第1四半期決算で、売上高が前年同期比4%増の8億6,200万ドルとなり、予想を5,300万ドル上回りました。これは、北米事業の低迷(-3%)を海外事業の好調(+15%)が相殺したことによるものです。関税コスト、不利な為替変動、インフレの影響で、売上総利益率は前年同期比450ベーシスポイント低下し44.9%となりました。調整後EPSは、前年同期の0.02ドルの損失から0.20ドルの損失へと悪化し、予想通りの結果となりました。市場の反応が鈍いのは、厳しい利益率を反映していると考えられますが、株価はガイダンスの12倍未満で取引されており、バリュエーションは依然として魅力的です。経営陣は、通期営業利益のガイダンスを5億8,000万ドル~6億3,000万ドル、調整後EPSを1.27ドル~1.39ドルに引き上げました。カテゴリー別の業績はまちまちで、乗り物(+17%)とアクションフィギュア(+21%)は好調だった一方、人形は8%減、乳幼児・幼児・未就学児向け商品は16%減となった。ホットウィールは17%増、バービーは16%減となった。MATはMattel163の買収を完了し、2億ドル相当の自社株買いを実施した。業績見通しの上方修正は、経営陣が下半期の改善に自信を持っていることを示唆していると考えられる。

Related Articles

Asia

Gentrack Group to Acquire Dubai Technology Partners in $10 Million Deal

Gentrack Group (ASX:GTK, NZE:GTK) signed an agreement to acquire Dubai-based airport technology and services provider Dubai Technology Partners for an enterprise value of $10 million, according to a Thursday filing with the Australian and New Zealand bourses.Dubai Technology Partners will be incorporated into the company's Veovo airports division, boosting its artificial intelligence-powered portfolio while also broadening its global footprint and strengthening its presence in the Middle East, per the filing.The deal, which will be funded through the company's existing cash reserves, is expected to add about NZ$3.5 million in fiscal 2026 revenue over four months post-completion, the filing said. It will also be marginally accretive to earnings before interest, taxes, depreciation, and amortization before integration costs, the filing added.The transaction is expected to be completed within a month, subject to standard conditions.The company's Australian shares were up 2% in recent Thursday trade, while its Kiwi shares added about 1%.

$ASX:GTK$NZE:GTK
Asia

Avita Medical Says Wound Care System Preparation Method Receives Regulatory Approval in Australia, New Zealand

Avita Medical (ASX:AVH) said its RECELL GO wound care system preparation method received regulatory clearance in Australia and New Zealand, allowing for commercialization in both markets for burn and acute wound treatment, according to a Thursday Australian bourse filing.It secured certification from Australia's Therapeutic Goods Administration and was listed on New Zealand's Web Assisted Notification of Devices database by Medsafe.RECELL GO combines a reusable, electricity-powered RECELL processing device with a single-use RECELL preparation kit, with one such kit capable of treating wounds up to 1,920 square centimeters, per the filing.Its exclusive distribution partner in Australia and New Zealand, Revolution Surgical, expects to begin the commercial launch within the coming weeks.Its shares rose over 2% in recent trading on Thursday.

$ASX:AVH
Asia

Dateline Resources Reports AU$96 Million Cash at Hand, Advances US Project BFS

Dateline Resources (ASX:DTR) completed a AU$50 million placement after the end of the March quarter, taking cash at hand, before costs, to AU$96 million to advance pre-construction activities at the Colosseum project in the US, according to a Thursday Australian bourse filing.The company said that the June quarter will see the release of the Colosseum gold bankable feasibility study and the rapid transition to project financing and planned construction, while exploration drilling will continue on the rare earths and gold targets at Colosseum with multiple rigs operating around the clock.At Music Valley, the geophysical interpretation will be used to guide the next phase of ground exploration, the filing added.

$ASX:DTR